YOUR BUSINESS AUTHORITY

Springfield, MO

Log in Subscribe

Eli Lilly pens $3.2B acquisition

Posted online

Eli Lilly has inked a $3.2 billion acquisition deal.

The company is buying Morphic Holding in a bid to expand its portfolio of inflammatory bowel disease drugs.

Morphic Holding's stock surged on the announcement.

Read more from Reuters.

Comments

No comments on this story |
Please log in to add your comment
Editors' Pick
Transportation officials discuss $471M Forward 44 initiative

Project work in Springfield corridor will continue into 2031.

Most Read
Update cookies preferences